Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 85.10
+0.75 (0.89%)
At close: Feb 27, 2026
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 147.66 billion as of February 27, 2026. Its market cap has increased by 151.78% in one year.
Market Cap
147.66B
Enterprise Value
140.91B
Revenue
12.52B
Ranking
n/a
PE Ratio
115.11
Stock Price
85.10
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 147.66B, an increase of 696.51%. That is a compound annual growth rate of 32.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 147.66B | 11.64% |
| Dec 31, 2025 | 132.27B | 120.60% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.79B |
| WuXi Biologics | 166.41B |
| Sino Biopharmaceutical | 108.15B |
| Akeso | 98.47B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.34B |
| RemeGen | 56.21B |
| 3SBio | 54.80B |
| Shanghai Henlius Biotech | 36.44B |